Homology modeling of human transketolase: description of critical sites useful for drug design and study of the cofactor binding mode
[DOI] [PMC free article] [PubMed] [Google Scholar] 280.Zhang Q., Delessa C.T., Augustin R., Bakhti M., Colldn G., Drucker D.J., Feuchtinger A., Caceres C.G., Grandl G., Harger A., et al
Clinicians should monitor thyroid function tests (TSH, free T4) at: Baseline before starting weight loss injections 6-8 weeks after achieving maintenance dose Every 3-6 months during active weight loss After significant weight stabilization Symptoms of overreplacement (palpitations, anxiety, tremor, heat intolerance) should prompt earlier testing
GLP-1s come with a high rate of side effects, which we will need to become skilled at avoiding and treating
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves lipid profile in patients with type 2 diabetes